Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Cancer Immunology, Immunotherapy : CII|December 4, 2013
Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancerChristian J Maine, Nor Haslinda Abdul Aziz, Jayanta Chatterjee, et al.
Future Oncology (London, England)|November 29, 2024
Homologous recombination deficiency testing in patients with high grade ovarian cancer: factors influencing test successAshton Hunt, Daria Ditri, Ankit Chadha, et al.
The Cochrane Database of Systematic Reviews|January 27, 2017
Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV testMaria Kyrgiou, Ilkka E J Kalliala, Anita Mitra, et al.
Cancer Research|January 18, 2018
Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial DiagnosisEdward Curry, Constanze Zeller, Nahal Masrour, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 19, 2015
Does fertility treatment increase the risk of uterine cancer? A meta-analysisSrdjan Saso, Louay S Louis, Farah Doctor, et al.
Biomaterials|July 25, 2013
Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfectionPei Yun Teo, Chuan Yang, James L Hedrick, et al.
Cancers|August 28, 2025
Postoperative Pain Following Gynecology Oncological Surgery: A Systematic Review by Tumor SiteSelina Chiu, Helen Staley, Xiaoxi Zhang, et al.
Cancers|December 11, 2025
The Oncological Follow-Up of Fertility Sparing Surgery for Mucinous Borderline Ovarian Tumours: A Retrospective Cohort StudyNicholas Anson, Patricia Cox, Lorraine S Kasaven, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|March 12, 2015
Survey of perceptions of health care professionals in the United Kingdom toward uterine transplantSrdjan Saso, Alex Clarke, Timothy Bracewell-Milnes, et al.
The American Journal of Pathology|January 30, 2013
The DNA methylomes of serous borderline tumors reveal subgroups with malignant- or benign-like profilesConstanze Zeller, Wei Dai, Edward Curry, et al.
Pageof 10